Literature DB >> 24322277

Congenital Factor VII Deficiency in Children at Tertiary Health Care Facility in Pakistan.

Muhammad Matloob Alam1, Bushra Moiz2, Karim Abdur Rehman3, Priyanka Jethwani3, Zehra Fadoo4.   

Abstract

This study presents the demographics, clinical spectrum, and outcome of patients with congenital factor VII (FVII) deficiency at a tertiary care center over a period of 12 years. Of the 49 patients, 27 (55%) patients were males. Consanguinity was found in 92% of the patients. The median age of symptom onset was 2.4 (interquartile range [IQR]: 1.1-6.5) years with a median age of 5.8 (IQR: 3.1-10) years at diagnosis. Life-threatening complications like intracranial bleeding (ICB) and intra-abdominal bleeding (IAB) were observed in 8 (16.4%) patients. We found that 11 (55%) of the 20 patients with FVII coagulant activity (FVIIc) <1% were either asymptomatic or showed mild phenotype. In contrast, 9 (53%) of the 17 patients with FVIIc >5% were affected by severe symptoms. Age <1 year was the only identified risk factor associated with development of life-threatening bleeding episodes (P = .042; odds ratio 6.46). Overall, 4 (8.2%) died as a consequence of ICB (3 patients) and IAB (1 patient).
© The Author(s) 2013.

Entities:  

Keywords:  bleeding disorder; children; consanguinity; factor VII deficiency; intracranial bleeding

Mesh:

Year:  2013        PMID: 24322277     DOI: 10.1177/1076029613515070

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  2 in total

1.  Novel IVS7+1G>T mutation of life-threatening congenital factor VII deficiency in neonates: A retrospective study in China.

Authors:  Juan He; Wei Zhou; Hui Lv; Li Tao; XiaoWen Chen; Ling Wang
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.889

2.  Congenital factor VII deficiency in Iraqi children (Single Centre Experience).

Authors:  Ali Ahmed Khudhair; Afrah Abdul-Mahdi Salih; Ausama Jamal Kadhum
Journal:  Pak J Med Sci       Date:  2020 Jan-Feb       Impact factor: 1.088

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.